| Structure | Chemical Name | CAS | MF |
|
N-[(2-O,3-O,4-O,6-O-Tetraacetyl-β-D-glucopyranosyl)thiocarbamoyl]-D-leucine
|
|
|
|
N-PENYL-PYRROLIDINONE
|
|
C10H11NO
|
|
|
Nope protein
|
|
|
|
|
NOPE protocol
|
|
|
|
|
nony phenyl polyoxyethylene (50～150) ether
|
|
C115～315H224～624O51～151
|
|
N-(2-o×o-2-phenyl-ethyl)forMaMide
|
73286-37-0
|
C9H9NO2
|
|
NPF-etoposide
|
125830-36-6
|
C27H24FNO7
|
|
N,2'-O,3'-O,5'-O-Tetrakis(trimethylsilyl)cytidine
|
56666-34-3
|
|
|
N,2'-O,3'-O,5'-O-Tetrakis(trimethylsilyl)adenosine
|
|
C22H45N5O4Si4
|
|
N-pepstatinyl-S-bimanyl-2-aminoethanethiol
|
80562-33-0
|
C46H78N8O10S
|
|
|
153N-6 peptide
|
|
|
|
6-[N-(3-(PERFLUOROHEXYL)PROPYL)-N-(3-(PERFLUOROOCTYL) PROPYL)AMINOSULFONYL]-1-HYDROXYBENZOTRIAZOLE
|
|
C26H16F30N4O3S
|
|
n-Perfluorooctanoic acid, ammonium salt 95%
|
|
C8H4F15NO2
|
|
N'-(PERFLUOROPYRIDIN-4-YL)ACETIMIDAMIDE
|
946054-18-8
|
C7H5F4N3
|
|
N2-perhydrocyclododeca[b]pyran-2-ylperhydrocyclododeca[b]pyran-2-amine
|
|
C30H55NO2
|
|
N1-perhydrocyclopenta[d]pyrimidin-2-ylidenbenzene-1-sulfonamide
|
|
C13H17N3O2S
|
|
|
nopinone
|
|
C9H14O
|
|
|
NP E SOLUTION
|
|
|
|
N-(4-((3-(P-ETHOXYPHENYL)UREIDO)SULFONYL)BENZYL)ACETAMIDE
|
|
C18H21N3O5S
|
|
N-(P-ETHOXYPHENYL)-N-(2-MORPHOLINO-2-OXOETHYL)ACETAMIDE
|
|
C16H22N2O4
|
|
N4-(p-ethoxyphenyl)-3-nitrosulphanilamide
|
22025-44-1
|
C14H15N3O5S
|
|
2-(N-(P-ETHOXYPHENYL)ACETAMIDO)-N,N-DIMETHYLACETAMIDE
|
3736-41-2
|
C14H20N2O3
|
|
353-NP, 4-(1-Ethyl-1,3-dimethylpentyl)phenol
|
186825-36-5
|
C15H24O
|
|
|
NP2ETHERCARBOXYLATE
|
|
|
|
|
N-[α-(p-Ethoxyphenyl)phenethyl]-4-morpholineacetamide
|
|
|
|
N1-(p-Ethoxyphenyl)-N2-(p-isopropoxyphenyl)acetamidine
|
84308-84-9
|
|
|
|
N-(p-Ethoxyphenyl)-3,4-dicarboxy-9,10-perylenedicarbimide
|
|
|
|
N-(p-Ethoxyphenyl)carbamic acid 4-thiocyanato-2-butynyl ester
|
14225-21-9
|
|
|
N-(p-Ethoxyphenyl)hydroxylamine
|
|
C8H11NO2
|
|
N-[3-(p-Ethoxyanilino)-1,3-dimethylbutylidene]-p-phenetidine
|
|
C22H30N2O2
|
|
N-[α-(p-Ethoxyphenyl)phenethyl]-1-piperidineacetamide
|
36838-40-1
|
C23H30N2O2
|
|
(+)-NOOTKATONE
|
28834-25-5
|
C15H22O
|
|
|
NOOTKATONE(SECONDARY STANDARD)
|
|
|
|
|
NOOTKATONE81%
|
|
|
|
nootkatone
|
91416-23-8
|
C15H22O
|
|
NOOTKATONE
|
4674-50-4
|
C15H22O
|
|
|
NOOTKATONE97%
|
|
|
|
|
NOOTKATONE50%
|
|
|
|
(-)-nootkatone,5,6-dimethyl-8-isopropenylbicyclo[4.4.0]dec-1-en-3-one
|
38427-78-0
|
C15H22O
|
|
|
NOOTKATONE(SG)
|
|
|
|
(N,3-O,4-O)-Triacetyl-D-GlucosaMine
|
|
C12H19NO8
|
|
(N,3-O,6-O)-Triacetyl-D-GlucosaMine
|
221069-48-3
|
C12H19NO8
|
|
(N,4-O,6-O)-Triacetyl-D-GlucosaMine
|
|
C12H19NO8
|
|
|
Nootropic Agents
|
|
|
|
|
N,2'-O,3'-O-Trimethyl-N-benzyl-5'-O-(2-O,3-O,4-O,6-O-tetramethyl-β-D-glucopyranosyl)adenosine
|
|
|
|
N,1-O,3-O-Triacetylsphingosine
|
2482-37-3
|
C24H43NO5
|
|
N,3'-O,5'-O-Tribenzoyl-2'-deoxycytidine
|
31501-22-1
|
C30H25N3O7
|
|
NPGB
|
19135-17-2
|
C14H13ClN4O4
|
|
N-(p-Fluorophenyl)-7-oxabicyclo(2.2.1)heptane-2,3-dicarboximide
|
30627-45-3
|
C14H12FNO3
|
|
N-((3-p-fluorophenyl-1-propyl)-4-methyl-4-piperidinyl)-4-amino-5-iodo-2-methoxybenzamide
|
155928-24-8
|
C23H29FIN3O3
|
|
N-(p-Fluorophenyl)-N,N'-dimethyl-N'-phenylethylenediamine
|
32857-41-3
|
|
|
2-[N-(p-Fluorobenzyl)-N-(2-dimethylaminoethyl)amino]pyridine
|
396-59-8
|
|
|
3-[N-(p-Fluorophenyl)formimidoyl]-1H-indole
|
22394-32-7
|
C15H11FN2
|
|
N-[9-(p-Fluorophenylimino)-9H-fluoren-2-yl]acetamide
|
|
C21H15FN2O
|
|
N'-(p-Fluoro-α-methylbenzyl)carbazic acid ethyl ester
|
1478-87-1
|
C11H15FN2O2
|
|
|
Nopp140
|
|
|
|
|
NO-OXTM TUBING 1/8IN OD X 1.5MM ID X 10FT
|
|
|
|
NOPOL
|
128-50-7
|
C11H18O
|
|
|
NOPP protocol
|
|
|
|
|
NOPP52 protein
|
|
|
|
|
Nop30 protein
|
|
|
|
|
NOP4 protein
|
|
|
|
|
Nop2 protein
|
|
|
|
|
Nop10 protein
|
|
|
|
|
NOP-1 protein
|
|
|
|
|
NOP77 protein
|
|
|
|
|
NOP10 protein, mammalian
|
|
|
|
|
Nop56 protein
|
|
|
|
|
NOP protocol
|
|
|
|
|
Nop5 protein
|
|
|
|
NOR-4
|
163180-50-5
|
C14H18N4O4
|
|
NOR-2
|
163032-71-1
|
C7H11N3O4
|
|
NOR-3
|
163180-49-2
|
C8H13N3O4
|
|
NOR-3
|
138472-01-2
|
C8H13N3O4
|
|
|
NOR-5
|
|
|
|
NOR-1
|
163032-70-0
|
C8H13N3O5
|
|
NOR 4
|
162626-99-5
|
C14H18N4O4
|
|
|
Noproxen Sod
|
|
|
|
Noprylsulfamide
|
|
C11H20N2O2S
|
|
|
2-NOR-5A-ANDROSTANE-1,3-DIACID, 17B-HYDROXY-17A-METHYL-1,3-SECO
|
|
C19H30O5
|
|
|
2-NOR-5A-ANDROSTANE-1,3-DIACID, 17B-HYDROXY-17A-METHYL-1,3-SECO (INTERMEDIATES OF OXANDROLONE)
|
|
|
|
|
19-NOR-4-ABDROSTANE-3-BETA, 17BETA DIOL
|
|
|
|
|
18-Norabieta-4(19),8,11,13-tetrene
|
|
|
|
|
19-Norabieta-8,11,13-trien-4β-ol
|
|
|
|
Noracycline
|
8015-14-3
|
C21H26O2.C20H28O
|
|
Nor-acetildenafil
|
949091-38-7
|
C24H32N6O3
|
|
Nor-acetildenafil-d8
|
1185117-07-0
|
C24H32N6O3
|
|
|
noracryl 65
|
53571-22-5
|
|
|
noracymethadol
|
1477-39-0
|
C22H29NO2
|
|
|
Noracymethadol Hydrochloride
|
|
|
|
|
NORACETYLMETHADOL
|
|
|
|
|
Nor acid(1-ethyl-e-fluoro-1-4,dihydro-4-oxo-7(chloro)-squinolinecarboxylix acid
|
|
|
|
Noracymethadol
|
5633-25-0
|
C22H30ClNO2
|
|
|
noracryl 100
|
63346-34-9
|
|
|
noracronycine
|
13161-79-0
|
C19H17NO3
|
|
Theodrenaline
|
13460-98-5
|
C17H21N5O5
|
|
3-NORADAMANTANEAMINE HYDROCHLORIDE
|
|
C9H16ClN
|
|
|
NORADRENALINE TARTRATE EPN(CRM STANDARD)
|
|
|
|
3-NORADAMANTANOL
|
|
C9H14O
|
|
3-NORADAMANTANAMINE
|
|
C9H15N
|